A iq option recusou a execução da ordem
First you throw away my outside and cook the inside. Then you eat my outside and throw away my inside. Corn on the cob. Because you throw away the husk, cook the corn. Then you eat the kernels, and throw away the cob. What runs, but never walks. Murmurs, but never talks. Has a bed, but never sleeps. And has a mouth, but never eats.
What bird can lift the most weight. What goes up as soon as the rain comes down. The more you take, the more you leave behind. I have all the knowledge you have. But I m so small, you can hold me in your fist. How much dirt is there in a hole that s 5 feet wide and 5 feet deep. What has three feet but can t walk.
If two s company and three s a crowd, what do four and five make. What travels the world while stuck in one spot. Name four days of the week that start with the letter t. Tuesday, Thursday, today, and tomorrow. What has four eyes but can t see. What s as big as an elephant but weighs absolutely nothing. What moves faster heat or cold. Forwards I m heavy but backwards I m not. Because you can always catch a cold.
A girl leaves home and turns left three times, only to return home facing two guys wearing masks. Who are the two guys. The catcher and the umpire. Beth s mother has three daughters. One is called Lara, the other one is Sara. What is the name of the third daughter. What gets bigger and bigger the more you take away from it. I have one head, one foot, and four legs.
We see it once in a year, twice in a week, and never in a day. If I have it, I don t share it. If I share it, I don t have it. What has one eye but can t see anything at all. CBD What it Does, Types of CBD, Side Effects, and Dosage 2020. 70 Abraham Lincoln Quotes on Life, Religion, and Freedom. The Unedited Truth About What You Really Sign Up For When Hiring A Life Coach. 6 Lessons You Learn When You Become An Orphan In Your 20s.
Shine Through The Darkness. What Each Zodiac Wishes They Could Change About Their Past. 50 Eleanor Roosevelt Quotes About Life, Success, and Equality. Previous Close 89. 95 x 1200 Ask 90. 24 52 Week Range 62. Volume 7,112,984. Market Cap 160. 758B Beta 5Y Monthly 0. 28 Volume 2,328,190 Avg. 72 PE Ratio TTM 20. 52 Earnings Date Oct 30, 2020 - Nov 03, 2020 Forward Dividend Yield 4.
26 Ex-Dividend Date Oct 14, 2020 1y Target Est 109. Subscribe to Premium to view Fair Value for ABBV. Weekly Stock List. This is among our most important themes for 2020, and stretches across industries. We think companies that raise their dividends consistently at a double-digit rate are delivering three important signals amid all the recent market volatility 1 the company s balance sheet is strong enough to pay a dividend; 2 management is focused on providing shareholder returns; and 3 management is confident enough in the near-term outlook to raise the payout aggressively.
This third factor is especially important as the pandemic upends the nation s recent record of long-term economic growth. Here are 13 stocks that meet our double-digit dividend test and are on the Argus BUY List. 10 Biggest Pharmaceutical Companies in the World in 2020. The pharmaceutical industry is a trillion dollar industry globally, achieving the milestone for the first time in 2014, and the biggest. 2 Biotech Stocks with Jaw-Dropping Growth Potential. Sorrento Therapeutics and Trillium Therapeutics could both be poised for another explosive move higher.
Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiative To Advance Health Equity and Diversity in Aesthetics. In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 click to skip ahead and see the top 3 pharma companies. Today Allergan Aesthetics, an AbbVie company NYSE ABBVand Skinbetter Science announced the launch of a new long-term, educational initiative DREAM Driving Racial Equity in Aesthetic Medicine.
The DREAM Initiative is committed to furthering the principles of racial and ethnic diversity, inclusion, respect and understanding in the fields of dermatology and plastic surgery. 2 Companies That Raised Their Dividends This Week. It s more evidence that dividend activity is improving for U. companies after coming under severe pressure earlier in the pandemic. Dividend Aristocrat AbbVie Declares Its Latest Payout; Yield Is 5.
One of the top dividend stocks in the healthcare sector is getting ready to hand out some cash to shareholders yet again. AbbVie NYSE ABBV announced Friday that its board of directors has declared a fresh quarterly dividend of 1. On Friday s closing share price, it would yield just under 5. AbbVie to Present New Data From 18 Abstracts at the International Congress of Parkinson s Disease and Movement Disorders. AbbVie NYSE ABBV today announced it will present results from several studies, including the DYSCOVER study evaluating the efficacy of DUODOPA levodopa carbidopa intestinal gel on the duration and severity of dyskinesia in patients with advanced Parkinson s disease PDat the 2020 International Congress of Parkinson s Disease and Movement Disorders Virtual Congress, September 12-16.
In total, 18 abstracts will be presented, including an overview of the pivotal Phase 3 study design for the investigational medicine ABBV-951 in patients with advanced PD, several studies evaluating the economic burden of PD, as well new and updated data evaluating AbbVie s neuroscience portfolio and pipeline. Drug Stocks Look Cheap. Here s Why, According to One Analyst. Drug stocks now fetch about 13. 5 times projected 2021 earnings, against a price to earnings ratio of 20. 2 times for the S P 500 index, leaving the pharmaceutical group at a 30 -plus discount to the overall market, writes J.
Morgan analyst Chris Schott in a client note. Drug stocks were at parity to the S P 500 P E ratio as recently as 2018. The pharmaceutical group is up about 2 so far this year, against a 7 gain in the S P 500. AbbVie Declares Quarterly Dividend. The board of directors of AbbVie Inc. NYSE ABBV today declared a quarterly cash dividend of 1. Pharma Stock Roundup AZN PFE s Coronavirus Vaccine Updates FDA Approvals. AstraZeneca AZN halts coronavirus vaccine study.
FDA approves Roche RHHBY and Glaxo s GSK medicines. 2 Top Dividend Stocks to Buy in a Stock Market Crash. These two pharma giants are unlikely to cut their dividend payments during the next market correction. Is AbbVie Stock a Buy. As the youngest of the pharma juggernauts, AbbVie NYSE ABBV is an exciting company because of its impressive size and lineup of popular pharmaceutical and biological products.
Since its spinoff from Abbott Laboratories NYSE ABT in 2013, AbbVie has built an attractive portfolio of drugs while exploring promising programs in oncology, immunology, neuroscience, and more. AbbVie is also attractive to investors thanks to its profitability, consistently growing revenues, and a meaty trailing dividend yield of 5. The Zacks Analyst Blog Highlights Alphabet, UnitedHealth, AbbVie, Adobe Systems and Anheuser-Busch. 3 Safe Blue Chip Stocks to Buy as Market Bounces Back After Tech Selloff.
There could be more selling ahead and the election might cause turbulence. Nonetheless, long-term investors might want to consider adding a few safe blue chip stocks to their portfolios. Top Stock Reports for Alphabet, UnitedHealth AbbVie. Halftime Report Traders Weigh In On AbbVie, JPMorgan And More. On CNBC s Fast Money Halftime Report, Stephanie Link said she likes AbbVie Inc NYSE ABBV. The stock trades at 30 discount to its peers, it has a great immunology franchise and it has synergies from the Allergan purchase.
With a yield of 5. 2she thinks it s a great quality stock for the long term. Josh Brown owns Barrick Gold Corp NYSE GOLD and he is looking for more opportunities to buy it into the mid- 20s. He believes the company is going to be very profitable over the next couple of years, given how low energy prices are and how elevated both gold and copper have become. Jon Najarian said he would buy JPMorgan Chase Co. NYSE JPM on dips. Sarat Sethi still likes Lowe s Companies Inc NYSE LOW. He would be a buyer on a pullback.
See more from Benzinga Jon Najarian Sees Unusual Activity In AMD and AGNC Investment Corp Fast Money Halftime Report Picks For September 8 McDonald s, Stewart Information And More Steve Grasso Prefers Cyclicals Over Tech Right Now C 2020 Benzinga. AbbVie Partners With Chinese Biotech for Cancer Candidate. AbbVie ABBV signs a collaboration agreement with China s I-Mab for developing commercializing the latter s lemzoparlimab to address various cancer types. AbbVie Inks Deal To Develop, Sell I-Mab s Cancer Therapy.
AbbVie announced that it has signed an exclusive global collaboration agreement with I-Mab to develop and sell the Chinese biotech company s lemzoparlimab drug candidate for the treatment of multiple cancers. Under the terms of the agreement, AbbVie ABBV will pay I-Mab 180 million in an upfront payment to exclusively license lemzoparlimab, also known as TJC4, along with 20 million in a milestone payment based on the Phase 1 results, for a total of 200 million.
I-Mab will be eligible to receive up to 1. 74 billion in success-based milestone payments for lemzoparlimab, of which 840 million are based on clinical development and regulatory approval milestones, with the remainder based on commercial milestones. Upon commercialization of lemzoparlimab, AbbVie will also pay tiered royalties from low-to-mid teen percentages on global net sales outside of greater China.
In addition, the two partners have the potential to expand the collaboration to additional transformative therapies, they said in the joint statement. Nasdaq-listed I-Mab IMAB stock closed 3. 6 higher at 37. 07 on Friday, while AbbVie was little changed. Lemzoparlimab is one of the main drug candidates among I-Mab s proprietary and innovative pipeline. It is designed to minimize inherent binding to normal red blood cells while preserving its strong anti-tumor activity, a critical attribute in potentially differentiating lemzoparlimab from other antibodies of the same class currently in development, the company said.
Cancer is the second-leading cause of death globally and the need for novel cancer therapies has never been more acute. The addition of I-Mab s novel CD47 programs complements our global clinical strategy in hematology and immuno-oncology, said AbbVie s chief scientific officer Thomas J. We have been impressed with what I-Mab has been able to accomplish in research and clinical development and we look forward to working together to make a meaningful difference in the lives of millions of patients globally.
I-Mab said results of its recent phase 1 clinical trial confirm possible differentiation of lemzoparlimab in drug safety and a more favorable pharmacokinetics profile in cancer patients. Results have shown that lemzoparlimab is well tolerated as a single agent at a dose range of up to 30 mg kg without any priming dose. Full data will be presented at an appropriate scientific conference later this year.
AbbVie shares have recovered after hitting a low in March and are now trading 3. 7 higher than at the start of the year on the back of its acquisition of Botox maker Allergan and solid revenues of Humira. Looking ahead, the 111. 38 average analyst price target indicates another 21 upside potential in the coming 12 months.
Before the collaboration announcement, Citigroup analyst Andrew Baum last week raised the stock s price target to 105 from 98 and reiterated a Buy rating. Baum believes that the underappreciated revenue and or durability upside from the company s marketed agents Skyrizi, Rinvoq and Imbruvica offsets the current risk from the recently announced congressional subpoena on AbbVie s drug pricing practices. Overall, ABBV scores 11 Buy ratings from Wall Street analysts adding up to a bullish Strong Buy consensus.
See Abbvie s stock analysis on TipRanks. Related News Novavax Pops 8 On Covid-19 Vaccine Data; Analyst Says Buy Amid Pullback Medtronic s First-Of-Its Kind Diabetes System For Young Children Approved AstraZeneca Rises On Report Trump Could Fast-Track Covid-19 Vaccine Candidate More recent articles from Smarter Analyst Buffett s Berkshire Cuts Stake In Wells Fargo As Analyst Flips To Buy United Airlines To Boost October Flight Capacity To 40 Cloudflare vs Fastly Which Stock Has More Upside Potential.
US Backs Microsoft s 10B JEDI Cloud Award; Wedbush Says JEDI Game Changer. AbbVie Partners With I-Mab for Cancer Drug. AbbVie NYSE ABBV has signed a collaboration agreement with Chinese clinical-stage biotechnology company I-Mab NASDAQ IMAB for the development and commercialization of lemzoparlimab, a monoclonal antibody in early-stage clinical testing that could be used to treat various cancers.
The antibody targets CD47, a protein that is overexpressed on the surface of many types of cancer cells and delivers a don t eat me signal to the body s immune system. Under the terms of the agreement, AbbVie will pay I-Mab 200 million now and up to 1. 74 billion in milestone payments in the future. AbbVie Inks 2. They are also new holdings in our Dividend Growth Separately Managed Account and in the Dividend Growers Total Return Trust, sponsored by SmartTrust.
9 Billion Cancer Deal With China s I-Mab. Bloomberg -- U. and Chinese drug developer I-Mab agreed to collaborate on a cancer treatment in a deal that could be worth more than 2. The deal gives North Chicago, Illinois-based AbbVie an exclusive global license to develop and sell I-Mab s cancer-fighting drug outside of Greater China, according to a statement on Friday.
drugmaker AbbVie Inc. The drug lemzoparlimab, also known as TJC4, is an antibody discovered by the Shanghai-based company that is used to treat multiple forms of cancer. AbbVie will pay I-Mab 180 million up front as well as 20 million based on recently-released clinical data, according to the statement. I-Mab could also receive as much as 1. 74 billion in milestone payments based on development, regulatory and sales criteria. The Chinese firm will get royalties from future sales of the drug.
The partnership also gives AbbVie a right of first negotiation to license further development and sales of two other lemzoparlimab-based antibodies developed by I-Mab. The potential combined value would be at least 1 billion in upfront and milestone payments. Separately, I-Mab also announced that a consortium led by Hillhouse Capital has agreed to invest 418 million through a private placement.
The deal includes an offering of 29. 1 million ordinary shares to the investors at a price equivalent to 33 for each of I-Mab s American depositary shares, according to another statement. The placement will also see the issue of warrants worth an additional 104. 5 million if fully exercised. Singapore sovereign wealth fund GIC Pte participated in the offering as well. I-Mab jumped as much as 17.
16 each in New York trading on Friday, while AbbVie rose as much as 1. I-Mab, which raised 114 million in a U. initial public offering in January, had been seeking a partner to jointly develop and sell lemzoparlimab in the world s biggest economy, Bloomberg News first reported in April. The therapy targets a do-not-eat-me signal that allows cancer cells to avoid being targeted by the patient s own immune system, according to I-Mab s website. The drug blocks the signal, allowing the immune system to engulf and eradicate the malignant cells.
I-Mab s deal with AbbVie is the latest large transaction in one of the hottest areas of pharmaceutical research cancer treatments that harness the immune system to fight tumors. Earlier this year, Gilead Sciences Inc. completed the acquisition of immuno-oncology firm Forty Seven Inc. In June, AbbVie agreed a cancer research and development pact with Danish biotechnology company Genmab A S that may generate payments of more than 3 billion.
Jefferies LLC is the lead placement agent on I-Mab s private placement, and China Renaissance Holdings Ltd. participated as a financial adviser. Adds share prices in sixth paragraph. For more articles like this, please visit us at bloomberg. comSubscribe now to stay ahead with the most trusted business news source. 2020 Bloomberg L. A Look Into AbbVie s Debt. Over the past three months, shares of AbbVie Inc. NYSE ABBV decreased by 4. Before having a look at the importance of debt, let s look at how much debt AbbVie has.
AbbVie s Debt According to the AbbVie s most recent balance sheet as reported on August 4, 2020, total debt is at 87. 43 billion, with 82. 06 billion in long-term debt and 5. 37 billion in current debt. Adjusting for 6. 02 billion in cash-equivalents, the company has a net debt of 81. Investors look at the debt-ratio to understand how much financial leverage a company has.
AbbVie has 149. 53 billion in total assets, therefore making the debt-ratio 0. As a rule of thumb, a debt-ratio more than 1 indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries.
For example, a debt ratio of 35 might be higher for one industry, whereas normal for another. Why Investors Look At Debt. Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives. Interest-payment obligations can impact the cash-flow of the company.
Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations. See more from Benzinga Earnings Scheduled For July 31, 2020 A Preview Of AbbVie s Earnings C 2020 Benzinga. AbbVie Partners With I-Mab for Cancer Treatment Candidate. AbbVie could end up making payments to I-Mab of more than 2 billion based on performance incentives should lemzoparlimab hit the market.
I-Mab s stock soars after AbbVie collaboration, which could be worth nearly 2 billion. Shares of I-Mab soared 17 in premarket trading Friday toward a record high, after the China-based biotechnology company announced a collaboration agreement with AbbVie Inc. to develop and commercialize I-Mab s lemzoparlimab for the treatment of multiple cancers. AbbVie s stock edged up 0.
1 ahead of the open. Under terms of the agreement, I-Mab will receive 200 million from AbbVie, including a 180 million upfront payment and 20 million in a milestone payment based on Phase 1 trial results. In addition, I-Mab will be eligible to receive up to 1. 74 billion in milestone payments, including up to 840 million for clinical development and regulatory approval milestones and the rest on commercialization milestones.
Separately, I-Mab said it entered into subscription agreements with a number of investors to raise 418 million through a private placement of shares. 9 to a record 42. Shares of I-Mab, which went public in January, have soared 49. 9 over the past three months through Thursday, while AbbVie s stock has slipped 1. 3 and the S P 500 has gained 11. The Daily Biotech Pulse AbbVie In-licenses I-Mab a iq option recusou a execução da ordem Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study.
Scaling The Peaks Biotech Stocks Hitting 52-week Highs Sept. 3 Akouos Inc NASDAQ AKUS FibroGen Inc NASDAQ FGEN reacted to an adverse clinical readout for a rival drug to treat chronic kidney disease related anemia Generation Bio Co NASDAQ GBIO Immunovant Inc NASDAQ IMVT Sutro Biopharma Inc NASDAQ STRO reacted to announcement concerning presentation of positive data for ovarian cancer drug Down In The Dumps Biotech Stocks Hitting 52-week Lows Sept.
3 Akebia Therapeutics Inc NASDAQ AKBA announced negative safety results for a late-stage study of drug to treat chronic kidney disease-induced anemia AnPac Bio-Medical Science Co Ltd - ADR NASDAQ ANPC Cyclacel Pharmaceuticals Inc NASDAQ CYCC Eyepoint Pharmaceuticals Inc NASDAQ EYPT Genfit SA NASDAQ GNFT Gritstone Oncology Inc NASDAQ GRTS Happiness Biotech Group Ltd NASDAQ HAPP Homology Medicines Inc NASDAQ FIXX Immatics NV NASDAQ IMTX Interpace Biosciences Inc NASDAQ IDXG Jaguar Health Inc NASDAQ JAGX Legend Biotech Corp NASDAQ LEGN Monopar Therapeutics Inc NASDAQ MNPR NanoVibronix Inc NASDAQ NAOV Odonate Therapeutics Inc NASDAQ ODT RA Medical Systems Inc NYSE RMED Recro Pharma Inc NASDAQ REPH Rockwell Medical Inc NASDAQ RMTI Soliton Inc NASDAQ SOLY Sun BioPharma, Inc.
NASDAQ SNBP Sunesis Pharmaceuticals, Inc. NASDAQ SNSS Teligent Inc NASDAQ TLGT Related Link Attention Biotech Investors Mark Your Calendar For September PDUFA DatesStocks In Focus Lilly Gets FDA Nod For 2 Higher Doses of Its Best-selling Diabetes Drug Eli Lilly And Co NYSE LLY said the FDA approved two additional doses of its Type 2 diabetes drug Trulicity.
5 mg doses based on data from the AWARD-11 study. The approval expands the label of once-weekly Trulicity to include 3 mg and 4. AbbVie will also pay royalties on lemzoparlimab sales outside of China. The phase 3 trial showed the additional doses led to further benefits in A1C and body weight reduction when compared to Trulicity 1. 5 mg, Lilly said. Trulicity fetched about 22. 5 of Lilly s total revenues in the recently reported second quarter and saw growth of 20 year-over-year.
Lilly said the two additional doses will be available in the U. in late September. OraSure s RNA Collection Device Gets EUA To Be Used In COVID-19 Test OraSure Technologies, Inc. NASDAQ OSUR said its ORAcollect RNA OR-100 collection device was included along with other devices in the FDA emergency use authorization, or EUA, granted to MiraDx Inc.a Los Angeles-based molecular genetics company.
MiraDx will utilize the device to collect oropharyngeal samples in its COVID-19 testing program for essential workers and first responders to help prevent the spread of COVID-19, OraSure said. The stock added 4. AbbVie To License I-Mab s Cancer Drug For Up to 1. 94B AbbVie Inc NYSE ABBV and I-Mab ADR NASDAQ IMAB said they have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab, an anti-CD47 monoclonal antibody internally discovered and developed by I-Mab for the treatment of multiple cancers.
21 in after-hours trading. In addition, the two partners have the potential to expand the collaboration to additional transformative therapies. Under the terms of the agreement, AbbVie will pay I-Mab 180 million in an upfront payment to exclusively license lemzoparlimab, along with 20 million in a milestone payment based on the Phase 1 results, for a total of 200 million. 74 billion in success-based milestone payments, of which 840 million are based on clinical development and regulatory approval milestones, with the remainder based on commercial milestonesSeparately, I-Mab said it has entered into definitive subscription agreements with a consortium of institutional investors led by Hillhouse Capital to raise approximately 418 million through a private placement.
25 in pre-market trading, while AbbVie was up 1. Savara Discontinues Mid-stage Cystic Fibrosis Study Due to COVID-19 and Availability of Rival Drug Savara Inc NASDAQ SVRA said it has decided to discontinue the ENCORE Phase 2a exploratory study, that is evaluating Molgradex for the treatment of nontuberculous mycobacterial lung infection in people living with cystic fibrosis. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor.
View more earnings on IBBI-Mab shares were adding 9. The company attributed the decision to discontinue to the impact of COVID-19 on patient recruitment and continued participation in the study as well as the availability of Vertex Pharmaceuticals Incorporated s NASDAQ VRTX new triple-combination CFTR modulator that has become a preferred treatment option for many cystic fibrosis patients. Savara shares fell 12. 20 in after-hours trading.
Roche s Test to Detect SARS-CoV-2 and Influenza A B Viruses Gets EUA Roche Holdings AG Basel OTC RHHBY said its cobas SARS-CoV-2 Influenza A B Test for use on the cobas 6800 8800 Systems has received EUA from the FDA This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19, Roche saidPuma s Licensing Partner Makes Regulatory Submission Seeking Label Expansion for Breast Cancer Drug Canadian specialty pharma Knight Therapeutics said it has submitted a supplement to a new drug submission to the Canadian regulatory agency to get a label expansion for Puma Biotechnology Inc s NASDAQ PBYI breast cancer drug Nerlynx.
Knight had in-licensed the drug to market it in Canada. Nerlynx was originally approved in Canada in July 2019 as an extended adjuvant treatment of women with early-stage HER2-overexpressed amplified breast cancer within one year after completion of Roche s Herceptin-based adjuvant therapy. The company now seeks to get approval for the drug as a treatment option for metastatic breast cancer.
Earnings Medical device company Cooper Companies Inc NYSE COO reported third-quarter revenues of 578. 2 million, down 15 year-over-year, and non-GAAP EPS of 2. The EPS, however, was ahead of the 1. 52-per share consensus estimate. For the fourth quarter, the company expects non-GAAP EPS of 3 to 3. 20 on revenues of 665 million to 693 million. 82 on revenues of 661. Analysts, on average, estimate EPS of 2.
In after-hours trading, the stock added 3. Offerings Obseva SA NASDAQ OBSV announced the pricing for its underwritten public offering of common shares, which would fetch the company 20 million in gross proceeds. The company also said a concurrent private placement priced at-the-market of common shares and 15-month purchase warrants would potentially raise an additional 23.
See more from Benzinga The Daily Biotech Pulse Amarin s Vascepa Appeal Hearing, Avid Bioservices Strong Q1, A Life Sciences Blank Check IPO C 2020 Benzinga. Like Dividends. I Bet You ll Love These 2 Stocks. Dividend stocks are a tried-and-true way of adding value to your portfolio -- when a company pays a generous dividend, this can be a sign of its potential as a reliable long-term investment.
If you re actively searching for dividend stocks, you ll definitely want to add these two large-cap healthcare companies to your list of contenders. AbbVie currently pays out a mouth-watering dividend yield of 5. Symbol Last Price Change Change ABT. Gilead Sciences, Inc. Bristol-Myers Squibb Company. CVS Health Corporation. Analyst Price Targets 16. Sector s Healthcare Industry Drug Manufacturers General Full Time Employees 47,000.
The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal BehÃ et s diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia CLLsmall lymphocytic lymphoma SLLmantle cell lymphoma, waldenstrÃ m s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus HCV ; TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids.
In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson s disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc. ; Janssen Biotech, Inc.
; Jacobio Pharmaceuticals; I-Mab; and Genmab A S. The company was incorporated in 2012 and is based in North Chicago, Illinois. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. 97 x 2900 Day s Range 89.
EXAMPLES FROM THE WEB FOR ACUITY. The doctor must correct, as far as possible, the want of acuity noticed. Antonyms for acuity. The acuity of hearing was no longer so pronounced and the sense of refreshment, although still present, was not intense. Synonyms for acuity. The portraits of certain artists in this unique volume recite the history of the critic s acuity and clairvoyance.
When they struck the water there was a hiss, which grew in volume and acuity as they skimmed the waves. Despite the breadth and acuity of his observations, Granger suggested remarkedly few changes. Careful investigation of olfactory acuteness would reveal the existence of such menstrual heightening of its acuity. One cannot imagine the degree of sharpness, of acuity, which may be obtained during sleep by these interior sensations.
RELATED WORDS AND SYNONYMS FOR ACUITY. acuity acuteness astuteness awareness brains brilliance cleverness comprehension cunning discernment discrimination farsightedness good taste grasp guile ingenuity insight intellect intelligence intuition judgment keenness perception percipience perspicacity perspicuity refinement sagacity sensitivity sharpness shrewdness smartness smarts understanding vision wisdom wit.
acuity acumen astuteness brain discernment intellect intelligence keenness penetration profoundness profundity sagacity sense sharpness weightiness. IQ acuity acumen agility alertness aptitude brainpower brains brightness brilliance capacity cleverness comprehension coruscation discernment gray matter intellect judgment luminosity mentality mind penetration perception perspicacity precocity quickness quotient reason sagacity savvy sense skill smarts subtlety the right stuff trenchancy understanding what it takes wit.
acuity acumen astuteness brain deepness discernment intellect intelligence keenness penetration profundity sagacity sense sharpness weightiness. IQ acuity acumen alertness aptitude brainpower brains brightness brilliance cleverness competence comprehension gray matter intellect judgment know-how mind perception perspicacity precocity reason savvy sense the right stuff understanding what it takes.
verify - Verify yourself. invite - Invite Link. config channel - Set cleverbot channel. verifyrole role - Set the role that will get after successful verification. opinions - Last Opinion and Average opinion. opinion 1-5 text - Send us opinion. dog - Random dog. meme - Random meme. ship name name - Shiping. triggered user - Triggered.
wasted user - Watsed. mc name - User info. level - Your Level. server - Server Info. id User Ping or member tag - Checking user id. - Some permission is needed. Babies with Down s syndrome are like any newborn babies. Advice for new parents - Down s syndrome. Some babies with Down s syndrome might need extra help. This could be with things like feeding. What life will be like. No one can tell you what life will be like for your child.
This is the same for children who do not have Down s syndrome. Children with Down s syndrome will have some level of learning disability it s not possible to know how this will affect them. There s support available for whatever you or your baby needs. Like any child they ll. have their own personality learn at their own pace have things that are important and unique to them.
Try not to think too far ahead and enjoy time with your baby. Where you can get support. It might help to speak to other parents, families and charities who know how you re feeling. For people with Down s syndrome, their parents and carers. Call their helpline 0333 1212 300 Visit their website www. uk Email info downs-syndrome. National Portage Association. For families with pre-school children with additional needs.
Page last reviewed 21 October 2019 Next review due 21 October 2022. They ll be eating, sleeping, crying, and needing love and cuddles just like all babies. L Eglise catholique ivoirienne a estimé que la candidature du président ivoirien Alassane Ouattara n est pas nécessaire. Alassane Ouattara même l Église catholique lui déconseille de se présenter. C était hier lundi 31 août 2020, que le cardinal Jean-Pierre Kutwachef de l Eglise catholique en Côte d Ivoirea fait cette déclaration, tout en exhortant à dialoguer.
Une radicalisation est constatée. Concernant le président Alassane Ouattarale cardinal a expliqué que son devoir régalien de garant de la Constitution appelle son implication courageuse, en vue de ramener le calme, de rassembler les Ivoiriens, de prendre le temps d organiser les élections dans un environnement pacifié par la réconciliation. Ces dernières se sont aggravées depuis la candidature du président Alassane Ouattara à sa propre réélection.
3ème mandat en Afrique Réaction d Alioune Tine, fondateur d Afrikajom Center. Mgr Kutwa a estimé que la vie socio-politique de la Côte d Ivoire prend un virage risqué. Selon lui, plus les élections approchent, plus une radicalisation des positions est constatée de part et d autre. Dans une lettre ouverte dénommée Appel au respect du Droit dans la concertationMgr Kutwa a écrit Je ne peux pas ne pas me tourner avec respect vers le président de la République, dont la candidature à ces prochaines élections n est pas nécessaire, à mon humble avis.
Saka Saley l alternance est pratiquement impossible avec le mode de parrainage retenu. Au moins 15 morts en août. Le cardinal Jean-Pierre Kutwa a par ailleurs invité, les uns et les autres à aller au dialogue et à la concertation, dans la recherche de solutions à cette crise qui n augure pas d un lendemain meilleur quant à l organisation paisible des élections. Notons qu au cours du mois d août dernier, l annonce de la candidature du président ivoirien a fait au moins 15 morts.
Il faut être un cr iminel pour accepter les actions crimi nelles de ce vampire. Touga dans Recul de la démocratie au Bénin Quatre Béninois adressent une lettre à Macron. Armée US la grave accusation de Trump contre le Pentagone. Young, creative and eager to commit secular heresies, they have become public enemy number one to beltway conservatives more hated, even, than Democrats or loopy progressives. An Establishment Conservative s Guide To The Alt-Right. A specter is haunting the dinner parties, fundraisers and think-tanks of the Establishment the specter of the alternative right.
The alternative right, more commonly known as the alt-right, is an amorphous movement. Some mostly Establishment types insist it s little more than a vehicle for the worst dregs of human society anti-Semites, white supremacists, and other members of the Stormfront set. They re wrong. Previously an obscure subculture, the alt-right burst onto the national political scene in 2015.
Although initially small in number, the alt-right has a youthful energy and jarring, taboo-defying rhetoric that have boosted its membership and made it impossible to ignore. It has already triggered a string of fearful op-eds and hit pieces from both Left and Right Lefties dismiss it as racist, while the conservative press, always desperate to avoid charges of bigotry from the Left, has thrown these young readers and voters to the wolves as well.
National Review attacked them as bitter members of the white working-class who worship father-Führer Donald Trump. Betsy Woodruff of The Daily Beast attacked Rush Limbaugh for sympathising with the white supremacist alt-right. BuzzFeed begrudgingly acknowledged that the movement has a great feel for how the internet works, while simultaneously accusing them of targeting blacks, Jews, women, Latinos and Muslims.
The amount of column inches generated by the alt-right a iq option recusou a execução da ordem a testament to their cultural punch. Part of this is down to the alt-right s addiction to provocation. But so far, no one has really been able to explain the movement s appeal and reach without desperate caveats and virtue-signalling to readers. The alt-right is a movement born out of the youthful, subversive, underground edges of the internet. 4chan and 8chan are hubs of alt-right activity.
For years, members of these forums political and non-political have delighted in attention-grabbing, juvenile pranks. Having once defended gamers, another group accused of harbouring the worst dregs of human society, we feel compelled to take a closer look at the force that s alarming so many. Are they really just the second coming of 1980s skinheads, or something more subtle. We ve spent the past month tracking down the elusive, often anonymous members of the alt-right, and working out exactly what they stand for.
THE INTELLECTUALS. There are many things that separate the alternative right from old-school racist skinheads to whom they are often idiotically comparedbut one thing stands out above all else intelligence. Long before the alt-right, 4channers turned trolling the national media into an in-house sport. Skinheads, by and large, are low-information, low-IQ thugs driven by the thrill of violence and tribal hatred.
The alternative right are a much smarter group of people which perhaps suggests why the Left hates them so much. They re dangerously bright. The origins of the alternative right can be found in thinkers as diverse as Oswald Spengler, H. L Mencken, Julius Evola, Sam Francis, and the paleoconservative movement that rallied around the presidential campaigns of Pat Buchanan. The French New Right also serve as a source of inspiration for many leaders of the alt-right.
The media empire of the modern-day alternative right coalesced around Richard Spencer during his editorship of Taki s Magazine. In 2010, Spencer founded AlternativeRight. com, which would become a center of alt-right thought. Alongside other nodes like Steve Sailer s a iq option recusou a execução da ordem, VDARE and American Renaissance, AlternativeRight. com became a gathering point for an eclectic mix of renegades who objected to the established political consensus in some form or another.
All of these websites have been accused of racism. Razib Khan, who lost an opportunity at the New York Times over his views on human biodiversity, now writes for the alt-right Unz Review. The so-called online manosphere, the nemeses of left-wing feminism, quickly became one of the alt-right s most distinctive constituencies. Gay masculinist author Jack Donovan, who edited AlternativeRight s gender articles, was an early advocate for incorporating masculinist principles in the alt-right.
His book, The Way Of Men, contains many a wistful quote about the loss of manliness that accompanies modern, globalized societies. That s the path we re on now. Steve Sailer, meanwhile, helped spark the human biodiversity movement, a group of bloggers and researchers who strode eagerly into the minefield of scientific race differences in a much less measured tone than former New York Times science editor Nicholas Wade.
Isolationists, pro-Russians and ex-Ron Paul supporters frustrated with continued neoconservative domination of the Republican party were also drawn to the alt-right, who are almost as likely as the anti-war left to object to overseas entanglements. It s tragic to think that heroic man s great destiny is to become economic man, that men will be reduced to craven creatures who crawl across the globe competing for money, who spend their nights dreaming up new ways to swindle each other.
Elsewhere on the internet, another fearsomely intelligent group of thinkers prepared to assault the secular religions of the establishment the neoreactionaries, also known as NRx. Neoreactionaries appeared quite by accident, growing from debates on LessWrong. com, a community blog set up by Silicon Valley machine intelligence researcher Eliezer Yudkowsky.
The purpose of the blog was to explore ways to apply the latest research on cognitive science to overcome human bias, including bias in political thought and philosophy. LessWrong urged its community members to think like machines rather than humans. Contributors were encouraged to strip away self-censorship, concern for one s social standing, concern for other people s feelings, and any other inhibitors to rational thought.
Led by philosopher Nick Land and computer scientist Curtis Yarvin, this group began a gleeful demolition of the age-old biases of western political discourse. It s not hard to see how a group of heretical, piety-destroying thinkers emerged from this environment nor how their rational approach might clash with the feelings-first mentality of much contemporary journalism and even academic writing. Liberalism, democracy and egalitarianism were all put under the microscope of the neoreactionaries, who found them wanting.
Asking people to see each other as human beings rather than members of a demographic in-group, meanwhile, ignored every piece of research on tribal psychology. NATURAL CONSERVATIVES. They are mostly white, mostly male middle-American radicals, who are unapologetically embracing a new identity politics that prioritises the interests of their own demographic. These motivations have been painstakingly researched by social psychologist Jonathan Haidt, and an instinct keenly felt by a huge swathe of the political population the conservative instinct.
Acclaimed social psychologist Jonathan Haidt described the conservative instinct in his 2012 book The Righteous Mind. In their politics, these new conservatives are only following their natural instincts the same instincts that motivate conservatives across the globe. Natural conservatives can broadly be described as the group that the intellectuals above were writing for. While they can certainly be accused of being overly-eager to bridge the gap between fact and value the truth of tribal psychology doesn t necessarily mean we should embrace or encourage itthese were the first shoots of a new conservative ideology one that many were waiting for.
Liberal democracy, they argued, had no better a historical track record than monarchy, while egalitarianism flew in the face of every piece of research on hereditary intelligence. The conservative instinct, as described by Haidt, includes a preference for homogeneity over diversity, for stability over change, and for hierarchy and order over radical egalitarianism. Their instinctive wariness of the foreign and the unfamiliar is an instinct that we all share an evolutionary safeguard against excessive, potentially perilous curiosity but natural conservatives feel it with more intensity.
They instinctively prefer familiar societies, familiar norms, and familiar institutions. An establishment Republican, with their overriding belief in the glory of the free market, might be moved to tear down a cathedral and replace it with a strip mall if it made economic sense. Immigration policy follows a similar pattern by the numbers, cheap foreign workers on H1B visas make perfect economic sense.
Such an act would horrify a natural conservative. But natural conservatives have other concerns chiefly, the preservation of their own tribe and its culture. For natural conservatives, culture, not economic efficiency, is the paramount value. More specifically, they value the greatest cultural expressions of their tribe. Their perfect society does not necessarily produce a soaring GDP, but it does produce symphonies, basilicas and Old Masters.
The natural conservative tendency within the alt-right points to these apotheoses of western European culture and declares them valuable and worth preserving and protecting. Needless to say, natural conservatives concern with the flourishing of their own culture comes up against an intractable nemesis in the regressive left, which is currently intent on tearing down statues of Cecil Rhodes and Queen Victoria in the UK, and erasing the name of Woodrow Wilson from Princeton in the U.
This follows decades in which left-wingers on campus sought to remove the study of dead white males from the focus of western history and literature curricula. These attempts to scrub western history of its great figures are particularly galling to the alt-right, who in addition to the preservation of western culture, care deeply about heroes and heroic virtues. In fairness, many establishment conservatives aren t keen on this stuff either but the alt-right would argue that they re too afraid of being called racist to seriously fight against it.
Which is why they haven t. Certainly, the rise of Donald Trump, perhaps the first truly cultural candidate for President since Buchanan, suggests grassroots appetite for more robust protection of the western European and American way of life. Alt-righters describe establishment conservatives who care more about the free market than preserving western culture, and who are happy to endanger the latter with mass immigration where it serves the purposes of big business, as cuckservatives.
Halting, or drastically slowing, immigration is a major priority for the alt-right. While eschewing bigotry on a personal level, the movement is frightened by the prospect of demographic displacement represented by immigration. The alt-right do not hold a utopian view of the human condition just as they are inclined to prioritise the interests of their tribe, they recognise that other groups Mexicans, African-Americans or Muslims are likely to do the same. As communities become comprised of different peoples, the culture and politics of those communities become an expression of their constituent peoples.
You ll often encounter doomsday rhetoric in alt-right online communities that s because many of them instinctively feel that once large enough and ethnically distinct enough groups are brought together, they will inevitably come to blows. In short, they doubt that full integration is ever possible. If it is, it won t be successful in the kumbaya sense.
Border walls are a much safer option. The alt-right s intellectuals would also argue that culture is inseparable from race. The alt-right believe that some degree of separation between peoples is necessary for a culture to be preserved. A Mosque next to an English street full of houses bearing the flag of St. George, according to alt-righters, is neither an English street nor a Muslim street separation is necessary for distinctiveness. Some alt-righters make a more subtle argument.
They say that when different groups are brought together, the common culture starts to appeal to the lowest common denominator. Instead of mosques or English houses, you get atheism and stucco. Ironically, it s a position that has much in common with leftist opposition to so-called cultural appropriation, a similarity openly acknowledged by the alt-right. It s arguable that natural conservatives haven t had real political representation for decades.
Since the 1980s, establishment Republicans have obsessed over economics and foreign policy, fiercely defending the Reagan-Thatcher economic consensus at home and neoconservative interventionism abroad. In matters of culture and morality, the issues that natural conservatives really care about, all territory has been ceded to the Left, which now controls the academy, the entertainment industry and the press. For those who believe in the late Andrew Breitbart s dictum that politics is downstream from culture, the number of writers, political candidates and media personalities who actually believe that culture is the most important battleground can be dispiriting.
Though Milo is trying his best. Natural liberals, who instinctively enjoy diversity and are happy with radical social change so long as it s in an egalitarian direction are now represented by both sides of the political establishment. Natural conservatives, meanwhile, have been slowly abandoned by Republicans and other conservative parties in other countries.
Having lost faith in their former representatives, they now turn to new ones Donald Trump and the alternative right. There are principled objections to the tribal concerns of the alt-right, but Establishment conservatives have tended not to express them, instead turning nasty in the course of their panicked backlash. National Review writer Kevin Williamson, in a recent article a iq option recusou a execução da ordem the sort of voters who back Trump, said that white working-class communities deserve to die.
Although the alt-right consists mostly of college-educated men, it sympathises with the white working classes and, based on our interviews, feels a sense of noblesse oblige. National Review has been just as directly unpleasant about the alt-right as it has, on occasion, been about white Americans in general. In response to concerns from white voters that they re going to go extinct, the response of the Establishment the conservative Establishment has been to openly welcome that extinction.
It s true that Donald Trump would not be possible without the oppressive hectoring of the progressive Left, but the entire media is to blame for the environment in which this new movement has emerged. For decades, the concerns of those who cherish western culture have been openly ridiculed and dismissed as racist. The alt-right is the inevitable result.
No matter how silly, irrational, tribal or even hateful the Establishment may think the alt-right s concerns are, they can t be ignored, because they aren t going anywhere. As Haidt reminds us, their politics is a reflection of their natural inclinations. In other words, the Left can t language-police and name-call them away, which have for the last twenty years been the only progressive responses to dissent, and the Right can t snobbishly dissociate itself from them and hope they go away either.
THE MEME TEAM. Earlier, we mentioned the pressure to self-censor. An establishment conservative might be mildly irked by such behaviour as they switch between the State of the Union and the business channels, but to a natural conservative, such cultural vandalism may just be their highest priority. But whenever such pressure arises in a society, there will always be a young, rebellious contingent who feel a mischievous urge to blaspheme, break all the rules, and say the unsayable.
Because it s funny. As Curtis Yarvin explains via email If you spend 75 years building a pseudo-religion around anything an ethnic group, a plaster saint, sexual chastity or the Flying Spaghetti Monster don t be surprised when clever 19-year-olds discover that insulting it is now the funniest fucking thing in the world. Because it is. These young rebels, a subset of the alt-right, aren t drawn to it because of an intellectual awakening, or because they re instinctively conservative.
Ironically, they re drawn to the alt-right for the same reason that young Baby Boomers were drawn to the New Left in the 1960s because it promises fun, transgression, and a challenge to social norms they just don t understand. These caricatures are often spliced together with Millennial pop culture references, from old 4chan memes like pepe the frog, to anime and My Little Pony references. Are they actually bigots. No more than death metal devotees in the 80s were actually Satanists. Just as the kids of the 60s shocked their parents with promiscuity, long hair and rock n roll, so too do the alt-right s young meme brigades shock older generations with outrageous caricatures, from the Jewish Shlomo Shekelburg to Remove Kebab, an internet in-joke about the Bosnian genocide.
For them, it s simply a means to fluster their grandparents. Currently, the Grandfather-in-Chief is Republican consultant Rick Wilson, who attracted the attention of this group on Twitter after attacking them as childless single men who jerk off to anime. Responding in kind, they proceeded to unleash all the weapons of mass trolling that anonymous subcultures are notorious for and brilliant at.
From digging up the most embarrassing parts of his family s internet history to ordering unwanted pizzas to his house and bombarding his feed with anime and Nazi propaganda, the alt-right s meme team, in typically juvenile but undeniably hysterical fashion, revealed their true motivations not racism, the restoration of monarchy or traditional gender roles, but lulz. It s hard to know for certain, but we suspect that unlike the core of the alt-right, these young renegades aren t necessarily instinctive conservatives.
Indeed, their irreverence, lack of respect of social norms, and willingness to stomp on other people s feelings suggest they may actually be instinctive libertarians. Certainly that s the case for a joyful contingent of Trump supporters who spend hours creating memes celebrating the God Emperor and tormenting his adversaries, such as Yiannopoulos ally PizzaPartyBen, who has amassed 40,000 followers on Twitter with his raucous antics.
Were this the 1960s, the meme team would probably be the most hellraising members of the New Left swearing on TV, mocking Christianity, and preaching the virtues of drugs and free love. Peter s Basilica or settling down in a traditional family unit. It s hard to imagine them reading Evola, musing at St. They may be be inclined to sympathise to those causes, but mainly because it annoys the right people.
Young people perhaps aren t primarily attracted to the alt-right because they re instinctively drawn to its ideology they re drawn to it because it seems fresh, daring and funny, while the doctrines of their parents and grandparents seem unexciting, overly-controlling and overly-serious. Of course, there is plenty of overlap.
Some true believers like to meme too. If you re a Buzzfeed writer or a Commentary editor reading this and thinking how childishwell. You only have yourself to blame for pompously stomping on free expression and giving in to the worst and most authoritarian instincts of the progressive left. This new outburst of creativity and taboo-shattering is the result. That s down to the age difference.
Millennials aren t old enough to remember the Second World War or the horrors of the Holocaust. They are barely old enough to remember Rwanda or 9 11. Racism, for them, is a monster under the bed, a story told by their parents to frighten them into being good little children. As with Father Christmas, Millennials have trouble believing it s actually real. Of course, just as was the case in history, the parents and grandparents just won t understand, man.
They ve never actually seen it for themselves and they don t believe that the memes they post on pol are actually racist. In fact, they know they re not they do it because it gets a reaction. Barely a month passes without a long feature in a new media outlet about the rampant sexism, racism or homophobia of online image boards. Another, more palatable, interpretation of these memes is that they are clearly racist, but that there is very little sincerity behind them.
For regular posters at these boards, that s mission accomplished. Just visit a pol thread, where posters nationalities are identified with small flags next to their posting IDs. You ll see flags from the west, the Balkans, Turkey, the Middle East, South America, and even, sometimes, Africa. Everyone on the anonymous board hurls the most vicious slurs and stereotypes each other, but like jocks busting each other s balls at the college bar, it s obvious that there s little real hatred present.
That is, until the 1488ers show up. Anything associated as closely with racism and bigotry as the alternative right will inevitably attract real racists and bigots. Calmer members of the alternative right refer darkly to these people as the 1488ers, and for all their talk of there being a iq option recusou a execução da ordem enemies to the right, it s clear from the many conversations we ve had with alt-righters that many would rather the 1488ers didn t exist.
These are the people that the alt-right s opponents wish constituted the entire movement. They re less concerned with the welfare of their own tribe than their fantasies of destroying others. 1488ers would likely denounce this article as the product of a degenerate homosexual and an ethnic mongrel. It s a reference to two well-known Neo Nazi slogans, the first being the so-called 14 Words We Must Secure The Existence Of Our People And A Future For White Children.
The second part of the number, 88, is a reference to the 8th letter of the alphabet H. Thus, 88 becomes HH which becomes Heil Hitler. Not very edifying stuff. The funny thing is, being Millennials, they re often quite diverse. But if you want to use the 1488ers to tarnish the entire alt-right, you need to do the same with Islamist killers and Islam and third-wave feminist wackos with the entire history and purpose of feminism. Which you might well be fine with but let s be consistent.
Alt-right vlogger Paul RamZPaul Ramsey describes them as LARPers or Live-Action Role Players a disparaging comparison to nerdy nostalgists who dress up as medieval warriors. Paul even goes as far as to suggest some in this toxic mix of kooks and ex-cons may be there solely to discredit the more reasonable white identitarians. Hitler is dead. Quit larping that it is perpetually 1933 Germany. I have no interest in the 1488 crowd.
A toxic mix of kooks and ex-cons turned informants. LARPing the Third Reich. Every ideology has them. Humourless ideologues who have no lives beyond their political crusade, and live for the destruction of the great. They can be found on Stormfront and other sites, not just joking about the race war, but eagerly planning it. They are known as Stormfags by the rest of the internet. Based on our research we believe this stands in stark contrast with the rest of the alt-right, who focus more on building communities and lifestyles based around their values than plotting violent revolution.
1488ers are the equivalent of the Black Lives Matter supporters who call for the deaths of policemen, or feminists who unironically want to KillAllMen. Of course, the difference is that while the media pretend the latter are either non-existent, or a tiny extremist minority, they consider 1488ers to constitute the whole of the alt-right.
Those looking for Nazis under the bed can rest assured that they do exist. On the other hand, there s just not very many of them, no-one really likes them, and they re unlikely to achieve anything significant in the alt-right. What little remains of old-school white supremacy and the KKK in America constitutes a tiny, irrelevant contingent with no purchase on public life and no support even from what the media would call the far-Right.
Admittedly, these days that includes anyone who votes Republican. THE ESTABLISHMENT S FRANKENSTEIN. Not all alt-righters will agree with our taxonomy of the movement. Hacker and white nationalist Andrew Auernheimer, better known as weev, responded in typically jaw-dropping fashion to our enquiries The tireless attempts of you Jews to smear us decent Nazis is shameful. There are a myriad of disagreements between its supporters over what they should build, but virtual unity over what they should destroy.
For decades since the 1960s, in fact the media and political establishment have held a consensus over what s acceptable and unacceptable to discuss in polite society. The politics of identity, when it comes from women, LGBT people, blacks and other non-white, non-straight, non-male demographics is seen as acceptable even when it descends into outright hatred. Any discussion of white identity, or white interests, is seen as a heretical offence.
It s a fact observed as early as 2008 by Yarvin. Ethnic pride is one thing. Hostility is another. But as progressives often observe they tend to travel together. It strikes me as quite incontrovertible that if an alien anthropologist were to visit Earth and collate expressions of hostility toward human subpopulations in Western culture today, the overwhelming majority would be anti-European. Anti-Europeanism is widely taught in schools and universities today.
Its converse most certainly is not. 0, why do non-European ethnocentrism and anti-European hostility not seem to bother you in the slightest. Do they maybe even strike you as, um, slightly cool. The current consensus offers, at best, mild condemnation of identity politics on the Left, and zero tolerance for identity politics on the right.
Even for us a gay man of Jewish descent and a mixed-ethnic half-Pakistani the dangers of writing on this topic loom large.